The DOI matches its Crossref record; 361 of the 361 references it cites were found in a registry or an index.
Metabolomics in cancer research and emerging applications in clinical oncology
Open accessAbstract
Cancer has myriad effects on metabolism that include both rewiring of intracellular metabolism to enable cancer cells to proliferate inappropriately and adapt to the tumor microenvironment, and changes in normal tissue metabolism. With the recognition that fluorodeoxyglucose‐positron emission tomography imaging is an important tool for the management of many cancers, other metabolites in biological samples have been in the spotlight for cancer diagnosis, monitoring, and therapy. Metabolomics is the global analysis of small molecule metabolites that like other ‐omics technologies can provide critical information about the cancer state that are otherwise not apparent. Here, the authors review how cancer and cancer therapies interact with metabolism at the cellular and systemic levels. An overview of metabolomics is provided with a focus on currently available technologies and how they have been applied in the clinical and translational research setting. The authors also discuss how metabolomics could be further leveraged in the future to improve the management of patients with cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–361 of 361
Pathophysiology of anorexia in the cancer cachexia syndrome
Ezeoke, C. C., & Morley, J. E. (2015) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12059 · Cited by 225
Vazquez, A., Kamphorst, J. J., Markert, E. K., Schug, Z. T., Tardito, S., & Gottlieb, E. (2016) · Journal of Cell Science · doi:10.1242/jcs.181016 · Cited by 225
Metabolic Dependencies in RAS-Driven Cancers
Kimmelman, A. C. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2425 · Cited by 224
Role of Physical Activity and Diet After Colorectal Cancer Diagnosis
Van Blarigan, E. L., & Meyerhardt, J. A. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.7799 · Cited by 222
Translational Metabolomics: Current Challenges and Future Opportunities
Pinu, F. R., Goldansaz, S. A., & Jaine, J. (2019) · Metabolites · doi:10.3390/metabo9060108 · Cited by 219
Control of glutamine metabolism by the tumor suppressor Rb
Reynolds, M. R., Lane, A. N., Robertson, B., Kemp, S., Liu, Y., Hill, B. G., Dean, D. C., & Clem, B. F. (2014) · Oncogene · doi:10.1038/onc.2012.635 · Cited by 216
Zachar, Z., Marecek, J., Maturo, C., Gupta, S., Stuart, S. D., Howell, K., Schauble, A., Lem, J., Piramzadian, A., Karnik, S., et al. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0785-8 · Cited by 216
Navigating freely-available software tools for metabolomics analysis
Spicer, R., Salek, R. M., Moreno, P., Cañueto, D., & Steinbeck, C. (2017) · Metabolomics · doi:10.1007/s11306-017-1242-7 · Cited by 215
MR spectroscopic imaging: Principles and recent advances
Posse, S., Otazo, R., Dager, S. R., & Alger, J. (2013) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.23945 · Cited by 211
Lv, M., Zhu, X., Wang, H., Wang, F., & Guan, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115147 · Cited by 208
VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma
Zhang, J., Wu, T., Simon, J., Takada, M., Saito, R., Fan, C., Liu, X.-D., Jonasch, E., Xie, L., Chen, X., et al. (2018) · Science · doi:10.1126/science.aap8411 · Cited by 203
Targeting Cancer Metabolism: Dietary and Pharmacologic Interventions
Vernieri, C., Casola, S., Foiani, M., Pietrantonio, F., de Braud, F., & Longo, V. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0615 · Cited by 202
Noninvasive Urinary Metabonomic Diagnosis of Human Bladder Cancer
Pasikanti, K. K., Esuvaranathan, K., Ho, P. C., Mahendran, R., Kamaraj, R., Wu, Q. H., Chiong, E., & Chan, E. C. Y. (2010) · Journal of Proteome Research · doi:10.1021/pr901173v · Cited by 200
Gouw, A. M., Margulis, K., Liu, N. S., Raman, S. J., Mancuso, A., Toal, G. G., Tong, L., Mosley, A., Hsieh, A. L., Sullivan, D. K., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.07.012 · Cited by 200
Liberti, M. V., Dai, Z., Wardell, S. E., Baccile, J. A., Liu, X., Gao, X., Baldi, R., Mehrmohamadi, M., Johnson, M. O., Madhukar, N. S., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.08.017 · Cited by 199
Self-citationDwarakanath, B., Singh, D., Banerji, A., Sarin, R., Venkataramana, N., Jalali, R., Vishwanath, P., Mohanti, B., Tripathi, R., Kalia, V., et al. (2009) · Journal of Cancer Research and Therapeutics · doi:10.4103/0973-1482.55136 · Cited by 194
Breitkopf, S. B., Ricoult, S. J. H., Yuan, M., Xu, Y., Peake, D. A., Manning, B. D., & Asara, J. M. (2017) · Metabolomics · doi:10.1007/s11306-016-1157-8 · Cited by 192
Poff, A. M., Ari, C., Seyfried, T. N., & D’Agostino, D. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065522 · Cited by 191
Harvei, S., Bjerve, K. S., Tretli, S., Jellum, E., Robsahm, T. E., & VATTEN, L. J. (1997) · International Journal of Cancer · Cited by 190
Caloric Restriction and Incidence of Breast Cancer
Michels, K. B. (2004) · JAMA · doi:10.1001/jama.291.10.1226 · Cited by 185
Boyd, D. B. (2003) · Integrative Cancer Therapies · doi:10.1177/1534735403259152 · Cited by 182
Goldvaser, H., Barnes, T. A., Šeruga, B., Cescon, D. W., Ocaña, A., Ribnikar, D., & Amir, E. (2018) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djx141 · Cited by 182
The Role of Sarcosine Metabolism in Prostate Cancer Progression
Khan, A. P., Rajendiran, T. M., Bushra, A., Asangani, I. A., Athanikar, J. N., Yocum, A. K., Mehra, R., Siddiqui, J., Palapattu, G., Wei, J. T., et al. (2013) · Neoplasia · doi:10.1593/neo.13314 · Cited by 178
Grosvenor, M., Bulcavage, L., & Chlebowski, R. T. (1989) · Cancer · doi:10.1002/1097-0142(19890115)63:2<330::aid-cncr2820630221>3.0.co;2-u · Cited by 177
Zhai, L., Ladomersky, E., Lauing, K. L., Wu, M., Genet, M., Gritsina, G., Győrffy, B., Brastianos, P. K., Binder, D. C., Sosman, J. A., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0120 · Cited by 177
PET Imaging of Glutaminolysis in Tumors by 18F-(2S,4R)4-Fluoroglutamine
Lieberman, B. P., Ploessl, K., Wang, L., Qu, W., Zha, Z., Wise, D. R., Chodosh, L. A., Belka, G., Thompson, C. B., & Kung, H. F. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.093815 · Cited by 176
The Clinical Pharmacology of Antineoplastic Agents: (Second of Two Parts)
Chabner, B. A., Myers, C. E., Coleman, C. N., & Johns, D. G. (1975) · New England Journal of Medicine · doi:10.1056/nejm197505292922206 · Cited by 175
Iozzo, P., Bucci, M., Roivainen, A., Någren, K., Järvisalo, M. J., Kiss, J., Guiducci, L., Fielding, B., Naum, A. G., Borra, R., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.05.039 · Cited by 174
Weight management and physical activity throughout the cancer care continuum
Demark‐Wahnefried, W., Schmitz, K. H., Alfano, C. M., Bail, J. R., Goodwin, P. J., Thomson, C. A., Bradley, D. W., Courneya, K. S., Befort, C. A., Denlinger, C. S., et al. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21441 · Cited by 172
Salivary Metabolomics: From Diagnostic Biomarker Discovery to Investigating Biological Function
Gardner, A., Carpenter, G. H., & So, P. (2020) · Metabolites · doi:10.3390/metabo10020047 · Cited by 172
Metabolic Characterization of Human Prostate Cancer with Tissue Magnetic Resonance Spectroscopy
Cheng, L. L., Burns, M. A., Taylor, J. L., He, W., Halpern, E. F., McDougal, W. S., & Wu, C.-L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4106 · Cited by 171
Detection of oncogenic IDH1 mutations using magnetic resonance spectroscopy of 2-hydroxyglutarate
Andronesi, O. C., Rapalino, O., Gerstner, E., Chi, A., Batchelor, T. T., Cahill, D. P., Sorensen, A. G., & Rosen, B. R. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67229 · Cited by 171
Therapeutic tumor-specific cell cycle block induced by methionine starvation in vivo.
Guo, H., Lishko, V. K., Herrera, H., et al. (1993) · PubMed · Cited by 169
Nutritional metabolomics and breast cancer risk in a prospective study
Playdon, M. C., Ziegler, R. G., Sampson, J. N., Stolzenberg-Solomon, R., Thompson, H. J., Irwin, M. L., Mayne, S. T., Hoover, R. N., & Moore, S. C. (2017) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.150912 · Cited by 168
Safety and Efficacy of Mitapivat in Pyruvate Kinase Deficiency
Grace, R. F., Rose, C., Layton, D. M., Galactéros, F., Barcellini, W., Morton, D. H., van Beers, E. J., Yaish, H., Ravindranath, Y., Kuo, K. H. M., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1902678 · Cited by 164
Metabolic consequences of oncogenic IDH mutations
Parker, S. J., & Metallo, C. M. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.05.003 · Cited by 158
Nγ-Aryl glutamine analogues as probes of the ASCT2 neutral amino acid transporter binding site
Esslinger, C. S., Cybulski, K. A., & Rhoderick, J. F. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.11.028 · Cited by 158
Seidel, A., Brunner, S., SEIDEL, P. R., Fritz, G., & Herbarth, O. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603164 · Cited by 157
Inhibition of glucose metabolism selectively targets autoreactive follicular helper T cells
Choi, S., Titov, A. A., Abboud, G., Seay, H. R., Brusko, T. M., Roopenian, D. C., Salek‐Ardakani, S., & Morel, L. M. (2018) · Nature Communications · doi:10.1038/s41467-018-06686-0 · Cited by 153
Teicher, B. A., Linehan, W. M., & Helman, L. J. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2587 · Cited by 152
Causal integration of multi‐omics data with prior knowledge to generate mechanistic hypotheses
Dugourd, A., Kuppe, C., Sciacovelli, M., Gjerga, E., Gabor, A., Emdal, K. B., Vieira, V., Bekker‐Jensen, D. B., Kranz, J., Bindels, E. M. J., et al. (2021) · Molecular Systems Biology · doi:10.15252/msb.20209730 · Cited by 149
Serkova, N. J., Gamito, E. J., Jones, R. H., O’Donnell, C. I., Brown, J. L., Green, S., Sullivan, H. T., Hedlund, T. E., & Crawford, E. D. (2008) · The Prostate · doi:10.1002/pros.20727 · Cited by 148
Kami, K., Fujimori, T., Sato, H., Sato, M., Yamamoto, H., Ohashi, Y., Sugiyama, N., Ishihama, Y., Onozuka, H., Ochiai, A., et al. (2012) · Metabolomics · doi:10.1007/s11306-012-0452-2 · Cited by 148
Wang, Q., Liberti, M. V., Liu, P., Deng, X., Liu, Y., Locasale, J. W., & Lai, L. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2016.11.013 · Cited by 147
Self-citationPancreatic Exocrine Insufficiency in Pancreatic Cancer
Vujasinović, M., Valente, R., Chiaro, M. D., Permert, J., & Löhr, M. J. (2017) · Nutrients · doi:10.3390/nu9030183 · Cited by 146
Ma, Y., Wang, W., Idowu, M. O., Oh, U., Wang, X.-Y., Temkin, S. M., & Fang, X. (2018) · Cancers · doi:10.3390/cancers11010033 · Cited by 145
Parenteral nutrition in cancer patients undergoing chemotherapy: a meta-analysis.
McGeer, A., Detsky, A. S., & O'Rourke, K. (1990) · PubMed · Cited by 142
Altered exocrine function can drive adipose wasting in early pancreatic cancer
Danai, L. V., Babic, A., Rosenthal, M. H., Dennstedt, E. A., Muir, A., Lien, E. C., Mayers, J. R., Tai, K., Lau, A. N., Jones-Sali, P., et al. (2018) · Nature · doi:10.1038/s41586-018-0235-7 · Cited by 141
Endocrine Late Effects in Childhood Cancer Survivors
Chemaitilly, W., Cohen, L. E., Mostoufi‐Moab, S., Patterson, B. C., Simmons, J. H., Meacham, L. R., van Santen, H. M., & Sklar, C. A. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.76.3268 · Cited by 141
Impact of obesity on prostate cancer recurrence after radical prostatectomy: Data from CaPSURE
Bassett, W. W., Cooperberg, M. R., Sadetsky, N., Silva, S., DuChane, J., Pasta, D. J., Chan, J. M., Anast, J. W., Carroll, P. R., & Kane, C. J. (2005) · Urology · doi:10.1016/j.urology.2005.05.040 · Cited by 140
Dietary Intake, Resting Energy Expenditure, Weight Loss and Survival in Cancer Patients
Bosaeus, I. G., Lundholm, K., & Daneryd, P. (2002) · Journal of Nutrition · doi:10.1093/jn/132.11.3465s · Cited by 139
A framework for examining how diet impacts tumour metabolism
Lien, E. C., & Vander Heiden, M. G. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0198-5 · Cited by 139
Self-citationSerine deprivation enhances antineoplastic activity of biguanides
Gravel, S.-P., Hulea, L., Toban, N., Birman, E., Blouin, M.-J., Zakikhani, M., Zhao, Y., Topisirovic, I., St-Pierre, J., & Pollak, M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-2643-t · Cited by 138
Beckmann, M., Parker, D., Enot, D. P., Duval, E., & Draper, J. (2008) · Nature Protocols · doi:10.1038/nprot.2007.500 · Cited by 136
Bladder Cancer Biomarker Discovery Using Global Metabolomic Profiling of Urine
Wittmann, B. M., Stirdivant, S. M., Mitchell, M. W., Wulff, J. E., McDunn, J. E., Li, Z., Dennis-Barrie, A., Neri, B. P., Milburn, M. V., Lotan, Y., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115870 · Cited by 136
Glutamate enrichment as new diagnostic opportunity in breast cancer
Budczies, J., Pfitzner, B. M., Győrffy, B., Winzer, K., Radke, C., Dietel, M., Fiehn, O., & Denkert, C. (2014) · International Journal of Cancer · doi:10.1002/ijc.29152 · Cited by 135
Metabolic Tumor Imaging Using Magnetic Resonance Spectroscopy
Glunde, K., & Bhujwalla, Z. M. (2011) · Seminars in Oncology · doi:10.1053/j.seminoncol.2010.11.001 · Cited by 135
Characterization of The Human Tear Metabolome by LC–MS/MS
Chen, L., Zhou, L., Chan, E. C. Y., Neo, J. C. H., & Beuerman, R. W. (2011) · Journal of Proteome Research · doi:10.1021/pr2004874 · Cited by 134
Guertin, K. A., Loftfield, E., Boca, S. M., Sampson, J. N., Moore, S. C., Xiao, Q., Huang, W.-Y., Xiong, X., Freedman, N. D., Cross, A. J., et al. (2015) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.096099 · Cited by 134
Nutrition and physical activity influence on breast cancer incidence and outcome
Chlebowski, R. T. (2013) · The Breast · doi:10.1016/j.breast.2013.07.006 · Cited by 133
Xie, K. C., & Plunkett, W. K. (1996) · PubMed · Cited by 133
Kung, C. K.-H., Hixon, J., Kosinski, P. A., Cianchetta, G., Histen, G., Chen, Y., Hill, C., Größ, S., Si, Y., Johnson, K. R., et al. (2017) · Blood · doi:10.1182/blood-2016-11-753525 · Cited by 133
Prospective analysis of circulating metabolites and breast cancer in EPIC
His, M., Viallon, V., Dossus, L., Gicquiau, A., Achaintre, D., Scalbert, A., Ferrari, P., Romieu, I., Onland‐Moret, N. C., Weiderpass, E., et al. (2019) · BMC Medicine · doi:10.1186/s12916-019-1408-4 · Cited by 133
Integrated, Step-Wise, Mass-Isotopomeric Flux Analysis of the TCA Cycle
Alves, T. C., Pongratz, R. L., Zhao, X., Yarborough, O. H., Sereda, S., Shirihai, O. S., Cline, G. W., Mason, G. F., & Kibbey, R. G. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.08.021 · Cited by 129
Kim, E.-Y., Chung, T., Han, C. W., Park, M.-J., Park, K. H., Jang, S. B., & Ha, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-40617-3 · Cited by 129
Zhang, X., Zhu, X., Wang, C., Zhang, H., & Cai, Z. (2016) · Oncotarget · doi:10.18632/oncotarget.11521 · Cited by 127
Zhang, F., Zhang, Y., Zhao, W., Deng, K., Wang, Z., Yang, C., Ma, L., Openkova, M. S., Hou, Y., & Li, K. (2017) · Oncotarget · doi:10.18632/oncotarget.16727 · Cited by 127
Metabolomics of Human Cerebrospinal Fluid Identifies Signatures of Malignant Glioma
Locasale, J. W., Melman, T., Song, S., Yang, X., Swanson, K. D., Cantley, L. C., Wong, E. T., & Asara, J. M. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.014688 · Cited by 126
Self-citationDual Requirement of Walker Carcinosarcoma 256 in vitro for Asparagine and Glutamine
Neuman, R. E., & McCoy, T. A. (1956) · Science · doi:10.1126/science.124.3212.124 · Cited by 125
Fathi, A. T., Sadrzadeh, H., Borger, D. R., Ballen, K. K., Amrein, P. C., Attar, E. C., Foster, J., Burke, M. E., Lopez, H. U., Matulis, C. R., et al. (2012) · Blood · doi:10.1182/blood-2012-06-438267 · Cited by 125
Chemical inhibition of acetyl-CoA carboxylase suppresses self-renewal growth of cancer stem cells
Corominas-Faja, B., Cuyàs, E., Gumuzio, J., Bosch‐Barrera, J., Leis, O., Martín, Á. G., & Menéndez, J. A. (2014) · Oncotarget · doi:10.18632/oncotarget.2059 · Cited by 124
A Western-Type Diet Accelerates Tumor Progression in an Autochthonous Mouse Model of Prostate Cancer
Llaverı́as, G., Danilo, C., Wang, Y., Witkiewicz, A. K., Daumer, K. M., Lisanti, M. P., & Frank, P. G. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100568 · Cited by 124
Struck‐Lewicka, W., Kordalewska, M., Wawrzyniak, R., Yumba-Mpanga, A., Markuszewski, M., Jacyna, J., Matuszewski, M., Kaliszan, R., & Markuszewski, M. J. (2015) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2014.12.026 · Cited by 123
Evans, W. K., Makuch, R., Clamon, G. H., Feld, R. D., Weiner, R. S., Moran, E. M., Blum, R., Shepherd, F. A., Jeejeebhoy, K. N., & DeWys, W. D. (1986) · Lung Cancer · doi:10.1016/s0169-5002(86)80124-6 · Cited by 123
The Clinical Pharmacology of Antineoplastic Agents
Chabner, B. A., Myers, C. E., Coleman, C. N., & Johns, D. G. (1975) · New England Journal of Medicine · doi:10.1056/nejm197505222922107 · Cited by 123
Metabolic gene alterations impact the clinical aggressiveness and drug responses of 32 human cancers
Sinkala, M., Mulder, N., & Martin, D. P. (2019) · Communications Biology · doi:10.1038/s42003-019-0666-1 · Cited by 122
Holder, A. M., Gonzalez-Angulo, A. M., Chen, H., Akçakanat, A., Do, K.-A., Symmans, W. F., Pusztai, L., Hortobágyi, G. N., Mills, G. B., & Meric‐Bernstam, F. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2354-4 · Cited by 119
Influence of whole body protein turnover rate on resting energy expenditure in patients with cancer.
Fearon, K. C. H., HANSELL, D. T., Preston, T., Plumb, J. A., Davies, J., Shapiro, D. M., Shenkin, A., Calman, K. C., & Burns, H. J. G. (1988) · PubMed · Cited by 118
Srivastava, S., Roy, R., Singh, S. K., Kumar, P., Dalela, D., Sankhwar, S., Goel, A., & Sonkar, A. A. (2009) · Cancer Biomarkers · doi:10.3233/cbm-2009-0115 · Cited by 116
Deja, S., Porębska, I., Kowal, A., Ząbek, A., Barg, W., Pawełczyk, K., Stanimirova, I., Daszykowski, M., Korzeniewska, A., Jankowska, R., et al. (2014) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2014.08.020 · Cited by 114
Recent Development of Small Molecule Glutaminase Inhibitors
Song, M., Kim, S., Im, C. Y., & Hwang, H.-J. (2018) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026618666180525100830 · Cited by 114
Pasikanti, K. K., Esuvaranathan, K., Hong, Y., Ho, P. C., Mahendran, R., Raman Nee Mani, L., Chiong, E., & Chan, E. C. Y. (2013) · Journal of Proteome Research · doi:10.1021/pr4000448 · Cited by 113
TBK1 Is a Synthetic Lethal Target in Cancer with VHL Loss
Hu, L., Xie, H., Liu, X., Potjewyd, F., James, L. I., Wilkerson, E., Herring, L. E., Xie, L., Chen, X., Cabrera, J. C., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0837 · Cited by 113
A Prospective Analysis of Circulating Plasma Metabolites Associated with Ovarian Cancer Risk
Zeleznik, O. A., Eliassen, A. H., Kraft, P. L., Poole, E. M., ROSNER, B. A., Jeanfavre, S., Deik, A., Bullock, K. H., Hitchcock, D. S., Ávila-Pacheco, J., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-2567 · Cited by 113
Amino Acid Profiles of Serum and Urine in Search for Prostate Cancer Biomarkers: a Pilot Study
Dereziński, P., Klupczyńska, A., Sawicki, W., Palka, J. A., & Kokot, Z. J. (2016) · International Journal of Medical Sciences · doi:10.7150/ijms.15783 · Cited by 112
Sykes, D. B. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1536748 · Cited by 111
Huang, G.-M., Jiang, Q., Cai, C., Qu, M., & Shen, W. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.12.036 · Cited by 109
Vazeille, C., Jouinot, A., Durand, J.-P., Neveux, N., Boudou, P., Huillard, O., Alexandre, J., Cynober, L., & Goldwasser, F. (2017) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.140434 · Cited by 109
Plasma metabolites as possible biomarkers for diagnosis of breast cancer
Park, J. W., Shin, Y., Kim, T. H., Kim, D., & Lee, A. (2019) · PLoS ONE · doi:10.1371/journal.pone.0225129 · Cited by 109
Marks, P. A., & Bishop, J. S. (1957) · Journal of Clinical Investigation · doi:10.1172/jci103419 · Cited by 108
Exploring cancer metabolism using stable isotope-resolved metabolomics (SIRM)
Bruntz, R. C., Lane, A. N., Higashi, R. M., & Fan, T. W. ‐. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r117.776054 · Cited by 108
Suijker, J., Oosting, J., Koornneef, A., Struys, E. A., Salomons, G. S., Schaap, F. G., Waaijer, C. J. F., Wijers‐Koster, P. M., Bruijn, I. H. B., Haazen, L. C. J. M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3723 · Cited by 107
Mediators involved in the cancer anorexia-cachexia syndrome: past, present, and future
Argilés, J. M. A., Busquets, S., Garcia‐Martínez, C., & López-Soriano, F. J. (2005) · Nutrition · doi:10.1016/j.nut.2005.02.003 · Cited by 107
Soth, M., Le, K., Francesco, M. E. D., Hamilton, M. M., Liu, G., Burke, J. P., Carroll, C. L., Kovacs, J. J., Bardenhagen, J., Bristow, C. A., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01398 · Cited by 107
An, Z., Chen, Y., Zhang, R., Song, Y., Sun, J., He, J., Bai, J., Dong, L., Zhan, Q., & Abliz, Z. (2010) · Journal of Proteome Research · doi:10.1021/pr100265g · Cited by 106
Puchades‐Carrasco, L., Lewintre, E. J., Pérez-Rambla, C., Garcia‐García, F., Lucas-Domínguez, R., Fariñas, S. C., Blasco, A., Dopazo, J., Camps, C., & Pineda‐Lucena, A. (2016) · Oncotarget · doi:10.18632/oncotarget.7354 · Cited by 106
Hypoxia-inducible factors regulate T cell metabolism and function
Phan, A. T., & Goldrath, A. W. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.08.004 · Cited by 103
Changes in plasma lipid and lipoprotein cholesterol and weight prior to the diagnosis of cancer.
Kritchevsky, S. B., Wilcosky, T. C., Morris, D. L., Truong, K. N., & Tyroler, H. A. (1991) · PubMed · Cited by 101
A review of metabolism-associated biomarkers in lung cancer diagnosis and treatment
Bamji, S. F., van Berkel, V. H., Miller, D. M., & Frieboes, H. B. (2018) · Metabolomics · doi:10.1007/s11306-018-1376-2 · Cited by 101
Metabolic sequelae associated with androgen deprivation therapy for prostate cancer
Faris, J. E., & Smith, M. R. (2010) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3283391fd1 · Cited by 100
Further leads on metabolic epidemiology of large bowel cancer.
Reddy, B. S., Mastromarino, A. J., & Wynder, E. L. (1975) · PubMed · Cited by 100
Rocha, C., Barros, A. S., Goodfellow, B. J., Carreira, I. M., Gomes, A., de Sousa, V. M. L., Bernardo, J., Carvalho, L., Gil, A. M., & Duarte, I. F. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu226 · Cited by 100
Metabolomic profiling of rare cell populations isolated by flow cytometry from tissues
DeVilbiss, A., Zhao, Z., Martin-Sandoval, M. S., Ubellacker, J. M., Tasdogan, A., Agathocleous, M., Mathews, T. P., & Morrison, S. J. (2021) · eLife · doi:10.7554/elife.61980 · Cited by 99
Plasma Metabolite Biomarkers for the Detection of Pancreatic Cancer
Xie, G., Lu, L., Qiu, Y., Ni, Q., Zhang, W., Gao, Y.-T., Risch, H. A., Yu, H., & Jia, W. P. (2014) · Journal of Proteome Research · doi:10.1021/pr501135f · Cited by 96
The Molecular Link from Diet to Cancer Cell Metabolism
Bose, S., Allen, A. E., & Locasale, J. W. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.05.018 · Cited by 96
Self-citationTHE CARBOHYDRATE METABOLISM OF TUMORS
Cori, C. F., & Cori, G. T. (1925) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)84944-4 · Cited by 95
Metabolic diseases and cancer risk
Faulds, M. H., & Dahlman‐Wright, K. (2011) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32834e0582 · Cited by 95
Nitrogen movement between host and tumor in mice inoculated with Ehrlich ascitic tumor cells.
Carrascosa, J. M., Martínez, P., & de Castro, I. N. (1984) · PubMed · Cited by 94
Biomarkers of Coordinate Metabolic Reprogramming in Colorectal Tumors in Mice and Humans
Manna, S. K., Tanaka, N., Krausz, K. W., Haznadar, M., Xue, X., Matsubara, T., Bowman, E. D., Fearon, E. R., Harris, C. C., Shah, Y. M., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.017 · Cited by 94
Metabolomic Markers of Altered Nucleotide Metabolism in Early Stage Adenocarcinoma
Wikoff, W. R., Grapov, D., Fahrmann, J. F., DeFelice, B. C., Rom, W. N., Pass, H. I., Kim, K., Nguyen, U. T., Taylor, S. L., Gandara, D. R., et al. (2015) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-14-0329 · Cited by 94
Metabolomics Biomarkers of Prostate Cancer: A Systematic Review
Kdadra, M., Höckner, S., Leung, H. Y., Kremer, W., & Schiffer, E. (2019) · Diagnostics · doi:10.3390/diagnostics9010021 · Cited by 90
Shah, S., Carriveau, W. J., Li, J., Campbell, S. L., Kopinski, P. K., Lim, H., Daurio, N. A., Trefely, S., Won, K., Wallace, D. C., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9666 · Cited by 89
Shariff, M. I. F., Gomaa, A. I., Cox, I. J., Patel, M., Williams, H. R. T., Crossey, M. M. E., Thillainayagam, A. V., Thomas, H. C., Waked, I. A., Khan, S. A., et al. (2011) · Journal of Proteome Research · doi:10.1021/pr101096f · Cited by 87
Progress in the development of fatty acid synthase inhibitors as anticancer targets.
Mullen, G. E., & Yet, L. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.08.087 · Cited by 85
Casciano, J. C., Perry, C. E., Cohen-Nowak, A. J., Miller, K. D., Voorde, J. V., Zhang, Q., Chalmers, S., Sandison, M. E., Liu, Q., Hedley, A., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-019-0711-3 · Cited by 84
Sarvin, B. A., Lagziel, S., Sarvin, N., Mukha, D., Kumar, P., Aizenshtein, E., & Shlomi, T. (2020) · Nature Communications · doi:10.1038/s41467-020-17026-6 · Cited by 84
Saadatian‐Elahi, M., Toniolo, P. G., Ferrari, P., Goudable, J., Akhmedkhanov, A., Zeleniuch‐Jacquotte, A., & Ríboli, E. (2002) · PubMed · Cited by 83
Zhou, W., Capello, M., Fredolini, C., Racanicchi, L., Piemonti, L., Liotta, L. A., Novelli, F., & Petricoin, E. F. (2011) · Journal of Proteome Research · doi:10.1021/pr2009274 · Cited by 83
Dissecting cell-type-specific metabolism in pancreatic ductal adenocarcinoma
Lau, A. N., Li, Z., Danai, L. V., Westermark, A. M., Darnell, A. M., Ferreira, R., Gocheva, V., Sivanand, S., Lien, E. C., Sapp, K. M., et al. (2020) · eLife · doi:10.7554/elife.56782 · Cited by 82
Shariff, M. I. F., Ladep, N. G., Cox, I. J., Williams, H. R. T., Okeke, E. N., Malu, A. O., Thillainayagam, A. V., Crossey, M. M. E., Khan, S. A., Thomas, H. C., et al. (2009) · Journal of Proteome Research · doi:10.1021/pr901058t · Cited by 81
Metabolomics Biomarkers for Breast Cancer
Günther, U. L. (2015) · Pathobiology · doi:10.1159/000430844 · Cited by 80
Hanaford, A. R., Alt, J., Rais, R., Wang, S. Z., Kaur, H., Thorek, D. L. J., Eberhart, C. G., Slusher, B. S., Martin, A. M., & Raabe, E. H. (2019) · Translational Oncology · doi:10.1016/j.tranon.2019.05.013 · Cited by 74
Pharmacologic Activation of PKM2 Slows Lung Tumor Xenograft Growth
Parnell, K. M., Foulks, J. M., Nix, R. N., Clifford, A., Bullough, J., LUO, B. H., Senina, A. V., Vollmer, D., Liu, J., McCarthy, V., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0026 · Cited by 72
Jayakumar, H., Ramanathan, P., Jayavelu, S., Dhandapani, H., Ganeshrajah, S., Singh, S. S., & Rajkumar, T. (2016) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2016.04.008 · Cited by 72
Parsons, J. K., Zahrieh, D., Mohler, J. L., Paskett, E. D., Hansel, D. E., Kibel, A. S., Liu, H., Seisler, D. K., Natarajan, L., White, M. M., et al. (2020) · JAMA · doi:10.1001/jama.2019.20207 · Cited by 72
Douglas, R. G., & Shaw, J. H. F. (1990) · British journal of surgery · doi:10.1002/bjs.1800770305 · Cited by 71
Metabolomics Biomarkers for Detection of Colorectal Neoplasms: A Systematic Review
Erben, V., Bhardwaj, M., Schrotz‐King, P., & Brenner, H. (2018) · Cancers · doi:10.3390/cancers10080246 · Cited by 71
Prospective serum metabolomic profiling of lethal prostate cancer
Huang, J., Mondul, A. M., Weinstein, S. J., Derkach, A., Moore, S. C., Sampson, J. N., & Albanes, D. (2019) · International Journal of Cancer · doi:10.1002/ijc.32218 · Cited by 70
Metabolomics analysis of human sweat collected after moderate exercise
Delgado-Povedano, M. M., Calderón-Santiago, M., Luque de Castro, M. D., & Priego-Capote, F. (2018) · Talanta · doi:10.1016/j.talanta.2017.09.028 · Cited by 68
Human tumors are methionine dependent in vivo.
Hoshiya, Y., Guo, H., Kubota, T., et al. (1995) · PubMed · Cited by 68
Vatten, L. J., Bjerve, K. S., Andersen, A., & Jellum, E. (1993) · European Journal of Cancer · doi:10.1016/s0959-8049(05)80146-7 · Cited by 67
Antitumor activity of 1-beta-D-arainofuranosylcytosine hydrochloride.
EVANS, J. S., Musser, E. A., Mengel, G. D., et al. (1961) · PubMed · Cited by 67
[18F](2 S ,4 S )-4-(3-Fluoropropyl)glutamine as a Tumor Imaging Agent
Wu, Z., Zha, Z., Li, G., Lieberman, B. P., Choi, S., Plöessl, K., & Kung, H. F. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500236y · Cited by 65
Tayyari, F., Gowda, G. A. N., Olopade, O. I., Berg, R., Yang, H. H., Lee, M. P., Ngwa, W. F., Mittal, S. K., Raftery, D., & Mohammed, S. I. (2018) · Oncotarget · doi:10.18632/oncotarget.24433 · Cited by 65
Antitumor Activity of 1- -D-Arabinofuranosylcytosine Hydrochloride
Evans, J. S., MUSSER, E. A., Mengel, G. D., et al. (1961) · Experimental Biology and Medicine · doi:10.3181/00379727-106-26335 · Cited by 65
García-Peris, P., Lozano, M. A., Velasco, C., Cuerda, C., Iriondo, T., Lesmes, I. B., Camblor, M., & Navarro, C. (2005) · Nutrition · doi:10.1016/j.nut.2005.03.006 · Cited by 63
Su, W., Chapman, N. M., Wei, J., Zeng, H., Dhungana, Y., Shi, H., Saravia, J., Zhou, P., Long, L., Rankin, S. L., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.10.022 · Cited by 63
Long, N. P., Yoon, S. J., Anh, N. H., Nghi, T. D., Lim, D. K., Hong, Y. J., Hong, S., & Kwon, S. W. (2018) · Metabolomics · doi:10.1007/s11306-018-1404-2 · Cited by 62
The effects of chemotherapy on energy metabolic aspects in cancer patients: A systematic review
Soom, T. V., Bakkali, S. E., Gebruers, N., Verbelen, H., Tjalma, W. A. A., & van Breda, E. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.07.028 · Cited by 62
Quantitative Analysis of the Physiological Contributions of Glucose to the TCA Cycle
Liu, S., Dai, Z., Cooper, D. E., Kirsch, D. G., & Locasale, J. W. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.09.005 · Cited by 61
Self-citationWuest, M., Trayner, B. J., Grant, T. N., Jans, H.-S., Mercer, J. R., Murray, D. L., West, F. G., McEwan, A. J. B., Wuest, F. R., & Cheeseman, C. I. (2011) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2010.11.004 · Cited by 60
Safety and efficacy of BAY1436032 in IDH1-mutant AML: phase I study results
Heuser, M., Palmisiano, N. D., Mantzaris, I., Mims, A. S., Dinardo, C. D., Silverman, L. R., Wang, E. S., Fiedler, W., Baldus, C. D., Schwind, S., et al. (2020) · Leukemia · doi:10.1038/s41375-020-0996-5 · Cited by 59
Nogueira, L., Lavigne, J. A., Chandramouli, G. V. R., Lui, H., Barrett, J. C., & Hursting, S. D. (2012) · Cancer Medicine · doi:10.1002/cam4.23 · Cited by 58
Babić, A., Rosenthal, M. H., Bamlet, W. R., Takahashi, N., Sugimoto, M., Danai, L. V., Morales‐Oyarvide, V., Khalaf, N. I., Dunne, R. F., Brais, L. K., et al. (2019) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-19-0370 · Cited by 58
Targeting Metabolic Changes in Cancer: Novel Therapeutic Approaches
Bobrovnikova-Marjon, E. V., & Hurov, J. (2014) · Annual Review of Medicine · doi:10.1146/annurev-med-092012-112344 · Cited by 57
Capillary Electrophoresis–Mass Spectrometry for Clinical Metabolomics
Ramautar, R. (2016) · Advances in clinical chemistry · doi:10.1016/bs.acc.2015.12.002 · Cited by 57
A novel therapeutic approach for anaplastic thyroid cancer through inhibition of LAT1
Enomoto, K., Sato, F., Tamagawa, S., Gündüz, M., Onoda, N., Uchino, S., Muragaki, Y., & Hotomi, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-51144-6 · Cited by 56
Epimetabolites: discovering metabolism beyond building and burning
Showalter, M. R., Čajka, T., & Fiehn, O. (2017) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2017.01.012 · Cited by 51
Observations on the anticancer activity of 6-mercaptopurine.
He, S., Thomson, Elion, G. B., & Hitchings, G. H. (1954) · PubMed · Cited by 49
Serum and Urinary Metabonomic Study of Human Osteosarcoma
Zhang, Z., Qiu, Y., Hua, Y., Wang, Y., Chen, T., Zhao, A., Chi, Y., Li, P., Hu, S., Li, J., et al. (2010) · Journal of Proteome Research · doi:10.1021/pr100480r · Cited by 48
Roig, B., Rodríguez-Balada, M., Samino, S., Lam, E. W. ‐., Guaita‐Esteruelas, S., Gomes, A., Correig, X., Borràs, J., Yanes, Ó., & Gumà, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-17897-8 · Cited by 42
Inhibitors of glucose transport and glycolysis as novel anticancer therapeutics
Qian, Y. (2014) · World Journal of Translational Medicine · doi:10.5528/wjtm.v3.i2.37 · Cited by 41
MALDI mass spectrometric imaging meets “omics”: recent advances in the fruitful marriage
Crecelius, A. C., Schubert, U. S., & von Eggeling, F. (2015) · The Analyst · doi:10.1039/c5an00990a · Cited by 39
Yam, C., Esteva, F. J., Patel, M. M., Raghavendra, A. S., Ueno, N. T., Moulder, S. L., Hess, K. R., Shroff, G. S., Hodge, S., Koenig, K. H., et al. (2019) · Investigational New Drugs · doi:10.1007/s10637-018-0700-z · Cited by 39
A case control study of sarcosine as an early prostate cancer detection biomarker
Ankerst, D. P., Liss, M. A., Zapata, D., et al. (2015) · BMC Urology · doi:10.1186/s12894-015-0095-5 · Cited by 38
Energy Balance and Metabolism After Cancer Treatment
Tonorezos, E. S., & Jones, L. W. (2013) · Seminars in Oncology · doi:10.1053/j.seminoncol.2013.09.011 · Cited by 36
Tumor Microenvironment – Selective Pressures Boosting Cancer Progression
Nunes, S. C. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-34025-4_2 · Cited by 33
Targeting HIF2α in Clear-Cell Renal Cell Carcinoma
Ricketts, C. J., Crooks, D. R., & Linehan, W. M. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.09.016 · Cited by 29
Wang, C., Peng, J., Kuang, Y., Zhang, J., & Dai, L.-M. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6758 · Cited by 24
Metabolic response to radiation therapy in patients with cancer
Klein, S., Luu, K., Sakurai, Y., Miller, R., Langer, M., & Zhang, X. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90144-4 · Cited by 3
Metabolic Biomarkers of Pancreatic Cancer
Mahajan, U. M., Li, Q., Kamlage, B., Lerch, M. M., & Mayerle, J. V. (2020) · Molecular and translational medicine · doi:10.1007/978-3-030-49476-6_5 · Cited by 1
Cited by
Small molecule metabolites: discovery of biomarkers and therapeutic targets
Qiu, S., Cai, Y., Yao, H., Lin, C., Xie, Y., Tang, S., & Zhang, A. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01399-3 · Cited by 884
Artificial intelligence-based multi-omics analysis fuels cancer precision medicine
He, X., Liu, X., Zuo, F., Shi, H., & Jing, J. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.12.009 · Cited by 445
Early screening and diagnosis strategies of pancreatic cancer: a comprehensive review
Yang, J., Xu, R., Wang, C., Qiu, J., Ren, B., & You, L. (2021) · Cancer Communications · doi:10.1002/cac2.12204 · Cited by 379
Metabolic reprogramming in the tumor microenvironment of liver cancer
Lin, J., Rao, D., Zhang, M., & Gao, Q. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01527-8 · Cited by 251
“Tumor cells often exhibit a high dependence on a reprogrammed metabolic state for stress adaptation and infinite proliferation, which can be leveraged for non-invasive cancer diagnosis [6–8].”
BackgroundOmics Technologies Improving Breast Cancer Research and Diagnostics
Orsini, A., Diquigiovanni, C., & Bonora, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612690 · Cited by 52
Metadata
- Authors
- Schmidt, D. R., Patel, R., Kirsch, D. G., Lewis, C. A., Vander Heiden, M. G., & Locasale, J. W.
- Venue
- CA: A Cancer Journal for Clinicians
- Publisher
- Wiley
- Published
- 2021-05-13
- Volume
- 71
- Issue
- 4
- Pages
- 333-358
- ISSN
- 0007-9235 (ISSN-L)
- 1542-4863
- OpenAlex
- W3162293114
- Cited by
- 648
- References
- 361
- FWCI
- 30.86
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.